Hydrogel Loaded with Components for Therapeutic Applications in Hypertrophic Scars and Keloids

Yixiu Zhong,Youfan Zhang,Beibei Lu,Zhenjun Deng,Zhiwen Zhang,Qi Wang,Jianglin Zhang
DOI: https://doi.org/10.2147/ijn.s448667
IF: 7.033
2024-01-26
International Journal of Nanomedicine
Abstract:Yixiu Zhong, 1 Youfan Zhang, 2 Beibei Lu, 1 Zhenjun Deng, 1 Zhiwen Zhang, 2 Qi Wang, 2 Jianglin Zhang 1 1 Department of Dermatology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, People's Republic of China; 2 Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China Correspondence: Yixiu Zhong; Jianglin Zhang, Email ; Hypertrophic scars and keloids are common fibroproliferative diseases following injury. Patients with pathologic scars suffer from impaired quality of life and psychological health due to appearance disfiguration, itch, pain, and movement disorders. Recently, the advancement of hydrogels in biomedical fields has brought a variety of novel materials, methods and therapeutic targets for treating hypertrophic scars and keloids, which exhibit broad prospects. This review has summarized current research on hydrogels and loaded components used in preventing and treating hypertrophic scars and keloids. These hydrogels attenuate keloid and hypertrophic scar formation and progression by loading organic chemicals, drugs, or bioactive molecules (such as growth factors, genes, proteins/peptides, and stem cells/exosomes). Among them, smart hydrogels (a very promising method for loading many types of bioactive components) are currently favoured by researchers. In addition, combining hydrogels and current therapy (such as laser or radiation therapy, etc.) could improve the treatment of hypertrophic scars and keloids. Then, the difficulties and limitations of the current research and possible suggestions for improvement are listed. Moreover, we also propose novel strategies for facilitating the construction of target multifunctional hydrogels in the future. Keywords: hydrogel, wound healing, hypertrophic scar, keloid Graphical Hypertrophic scars and keloids are both benign fibrous growth diseases usually caused by skin injury. Hypertrophic scars are soft, with normal skin color, do not extend beyond the boundary of the injury, may regress over time, and histologically display well-organized type III collagen bundles. Keloids are clinically manifested as hard-raised and pigmented scars that grow beyond the original wound area, have high recurrence rates and histologically display disorganized, large thick, collagen type I and III bundles. 1 Giant hypertrophic scars and keloids can cause disfiguration and movement disorders, accompanied by functional symptoms of pruritus and pain, which severely damage their quality of life and psychological health. 2 In addition to injury, ethnicity, age, skin tension, and genetic inheritance were also closely associated with the occurrence and progression of keloids. 3 Hispanic and African populations are more prone to keloids, with an estimated incidence of 5–16%, than white populations. 4 Keloids in young individuals tend to progress faster than those in old individuals. 3 The most vulnerable sites are the shoulders, backs, chests, and earlobes with high tension. 5–7 Current treatments for hypertrophic scars and keloids include surgical excision, glucocorticoid injection, radiation therapy, and mesenchymal stem cells. 8 Meta-analysis revealed that surgery combined with radiotherapy had a lower recurrence rate than radiotherapy (22% vs 37%) in keloids. 9 However, there is no optimal treatment that can completely prevent the formation, progression, and recurrence of pathologic scars; thus, more efforts need to be dedicated to developing novel therapeutic agents for hypertrophic scars and keloids. Pathologic scarring is caused by abnormal wound healing (Figure 1). To improve the treatment of hypertrophic scars and keloids, we must understand the wound healing process. Wound healing is now considered a complicated process consisting of four interrelated stages: hemostasis. Inflammatory, proliferative, and remodelling, involving a variety of cells secreting different cytokines and other biomolecules. 10,11 Figure 1 Four stages of wound healing. Note: ( A ) Hemostais stage, ( B ) inflammatory stage, ( C ) proliferation stage, ( D ) remodelling stage. Hemostasis usually lasts 2–3 hours, forming fibrin plugs and triggering the release of inflammatory mediators by platelets. Immune cells such as neutrophils and macrophages are recruited by cytokines, initiating the inflammatory phase. 12 The inflammatory stage initiates immediately after skin injury and typically lasts from hours to two or -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology
What problem does this paper attempt to address?